CMPX position history
The shares of Compass Therapeutics (CMPX) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 2,532,419 shares, $14M, 1.9% of portfolio, New
- 2026 Q1: 1,514,504 shares, $8M, 1.2% of portfolio, Reduce −40.2%
- 2026 Q2: 5,831,813 shares, $13M, 1.8% of portfolio, Add +285.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|